Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.
about
Metabolic imaging of human kidney triglyceride content: reproducibility of proton magnetic resonance spectroscopy.The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats.Renal lipid metabolism and lipotoxicity.Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammationIncreased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension.Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodelingAntifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.Kidney pathological changes in metabolic syndrome: a cross-sectional study.Renal iron overload in rats with diabetic nephropathy.LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice.The metabolic syndrome and chronic kidney disease.Renal C3 complement component: feed forward to diabetic kidney disease.Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.Treatment of the post-ischaemic inflammatory syndrome of diabetic nephropathy.Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation.Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy.
P2860
Q30620037-4EDC4355-0019-4AF0-8A06-0DEC0C4A3758Q33570124-21083C28-2848-46A6-9662-FE5D391FEB81Q34721238-6B7339BD-32E8-452B-A2F1-510B9DBD0B98Q34825296-1575276A-C944-43ED-B00C-5F0179E41862Q35070137-D8C914E6-65BD-4D77-B830-F552A2DE0CE0Q36995173-C4BCC825-EAA2-4E49-A0F5-99A273EBAAEAQ37093818-58063307-E7EA-4D97-94B1-A504E5900D32Q37193667-BA5A53EB-AB22-4A4D-8A37-F644A3735B4AQ37306331-3828A4AA-A9F8-499B-A1F5-454AB2E6C5DDQ37395484-9FD91583-AA4B-4649-B73E-3A4E5DFA8C6BQ38565776-420FCEF2-021C-45EE-83D3-383BFC3385D9Q38911361-C0F9CB20-B5DA-48BD-890D-EE94C9179162Q39056509-13BA52E7-9CF0-42C1-829D-EE9670B68FCDQ41463448-C1082A4B-0977-49F6-8A40-5C5444512E0CQ42707950-7574039B-78E9-4578-B4FD-6A6FF04AC572Q43064230-B1DE10DB-F575-4FA5-A9FC-B5DEE9FA9F00Q43269536-29DC16CE-ACEE-4DB0-9E78-7F5A50E180CBQ45769086-D19A36F4-EBB2-49BA-BB71-7AC7FB5721BE
P2860
Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@en
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@nl
type
label
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@en
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@nl
prefLabel
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@en
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@nl
P2093
P2860
P1476
Lipotoxic and inflammatory phe ...... olic syndrome and nephropathy.
@en
P2093
C Subah Packer
Constance Temm
Jesus Dominguez
Katherine J Kelly
Pengfei Wu
P2860
P304
P356
10.1152/AJPRENAL.00021.2007
P577
2007-06-27T00:00:00Z